News search

RESILIENCE is a clinical trial funded by the European Commission (H2020 Programme) that aims to reduce the prevalence of heart failure in cancer survivors

The new study, published in the journal Circulation, opens a new avenue of research into treatments for the atherosclerosis associated with progeria

Two studies carried out at the CNIC provide key information about a newly identified cardiovascular risk factor, clonal hematopoiesis, and its treatment with the ancient medication colchicine

A study by the CNIC and Fundación SHE, supported by “la Caixa” Foundation, demonstrates that schools are a crucial environment for health promotion in children

iSuRe-HadCre promises to become an essential tool for biomedical research using mouse models to modify and understand gene function

Globally, cardiovascular diseases due to atherosclerosis – the build-up of plaque in arteries – are the leading cause of death. A new Danish-Spanish research collaboration aims to develop methods to detect atherosclerosis at earlier ages and encourage prevention. Denmark’s Novo Nordisk Foundation has granted up to EUR 23 million to cover the first 2.5 years of the REACT initiative. The initiative is expected to run for 8 years in total